DI STEFANO, ROSARIO FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 1.131
EU - Europa 814
AS - Asia 525
OC - Oceania 65
AF - Africa 53
SA - Sud America 23
Totale 2.611
Nazione #
US - Stati Uniti d'America 1.076
IT - Italia 225
CN - Cina 161
GB - Regno Unito 126
IE - Irlanda 123
SG - Singapore 96
SE - Svezia 69
AU - Australia 64
CA - Canada 44
IN - India 40
DE - Germania 32
ES - Italia 32
KR - Corea 32
IR - Iran 31
VN - Vietnam 28
PL - Polonia 26
UA - Ucraina 26
HK - Hong Kong 25
ID - Indonesia 23
BE - Belgio 20
DK - Danimarca 20
TR - Turchia 20
JP - Giappone 19
FR - Francia 17
NL - Olanda 15
CH - Svizzera 11
PK - Pakistan 11
AT - Austria 10
FI - Finlandia 10
ZA - Sudafrica 10
NG - Nigeria 9
PH - Filippine 9
BR - Brasile 8
IQ - Iraq 8
KE - Kenya 8
RS - Serbia 8
TW - Taiwan 8
GH - Ghana 7
MX - Messico 7
PT - Portogallo 7
CZ - Repubblica Ceca 6
GR - Grecia 6
CO - Colombia 5
EG - Egitto 5
LT - Lituania 5
MA - Marocco 4
NO - Norvegia 4
SK - Slovacchia (Repubblica Slovacca) 4
CL - Cile 3
HR - Croazia 3
HU - Ungheria 3
LY - Libia 3
MY - Malesia 3
TN - Tunisia 3
VE - Venezuela 3
AR - Argentina 2
BJ - Benin 2
KZ - Kazakistan 2
MT - Malta 2
NE - Niger 2
NI - Nicaragua 2
PR - Porto Rico 2
RO - Romania 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BO - Bolivia 1
CY - Cipro 1
EC - Ecuador 1
IL - Israele 1
JO - Giordania 1
MO - Macao, regione amministrativa speciale della Cina 1
NZ - Nuova Zelanda 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
UZ - Uzbekistan 1
Totale 2.611
Città #
Chandler 193
Dublin 120
Singapore 67
Ashburn 54
Fairfield 54
Nyköping 53
Beijing 45
Torino 36
Turin 34
Redwood City 32
Wilmington 26
London 25
New York 25
Woodbridge 25
Seattle 22
Binbrook 20
Houston 20
Medford 20
Pisa 20
Princeton 20
Santa Clara 19
Jakarta 18
Kalundborg 18
Cambridge 17
Dong Ket 16
Peoria 16
Fremont 14
Warsaw 14
Chennai 13
Hangzhou 13
Los Angeles 13
Milan 13
Guangzhou 12
Seoul 11
Shanghai 11
Brisbane 10
Dearborn 10
Genoa 9
Philadelphia 9
Istanbul 8
Madrid 8
San Diego 8
Tokyo 8
Vienna 8
Adelaide 7
Boston 7
Central 7
Gangdong-gu 7
Hong Kong 7
Isfahan 7
Jacksonville 7
Liverpool 7
Sydney 7
Taipei 7
Ann Arbor 6
Belgrade 6
Boardman 6
Chengdu 6
Chicago 6
Derby 6
Duncan 6
Kraków 6
Munich 6
Nairobi 6
Noblesville 6
Wuhan 6
Bognor Regis 5
Bronx 5
Camden 5
Davao City 5
Ghent 5
Hyderabad 5
Johannesburg 5
Kolkata 5
Lappeenranta 5
Melbourne 5
Shijiazhuang 5
Staten Island 5
Valencia 5
Abuja 4
Buffalo 4
Croydon 4
Edmonton 4
Helsinki 4
Jinan 4
Molenbeek-Saint-Jean 4
Moncalieri 4
Montreal 4
Odunpazari 4
Palo Alto 4
Perth 4
Piemonte 4
Rome 4
Tehran 4
Wuxi 4
Ankara 3
Athens 3
Belfast 3
Berlin 3
Bethesda 3
Totale 1.493
Nome #
Hormonal treatment and quality of life of prostate cancer patients: new evidences 720
Renal cell carcinoma (RCC): Fatter is better? A review on the role of obesity in RCC 234
Quality of life assessment and reporting in colorectal cancer: A systematic review of phase III trials published between 2012 and 2018 178
Deficiencies in health-related quality of life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016 160
Fatigue in lung cancer patients: symptom burden and management of challenges. 134
Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data 105
Quality of life analysis in lung cancer: A systematic review of phase III trials published between 2012 and 2018 94
SARS-CoV-2 Infection in Cancer Patients: A Picture of an Italian Onco-Covid Unit 93
Prognostic role of the duration of response to androgen deprivation therapy in patients with metastatic castration resistant prostate cancer treated with enzalutamide or abiraterone acetate 92
LATITUDE and other coordinates in quality of life of prostate cancer patients 83
Italian survey on the clinical management of non-small cell lung cancer patients during the COVID-19 pandemic: A lesson for the second wave 75
Quality-of-Life Assessment and Reporting in Prostate Cancer: Systematic Review of Phase 3 Trials Testing Anticancer Drugs Published Between 2012 and 2018 57
Chemotherapy-Induced Neutropenia and Outcome in Patients With Metastatic Castration-Resistant Prostate Cancer Treated With First-Line Docetaxel 55
Role of radiotherapy in improving activity of immune-modulating drugs in advanced renal cancer: Biological rationale and clinical evidences 49
Bipolar androgen therapy in prostate cancer: Current evidences and future perspectives 48
Metastatic Renal Medullary Carcinoma Treated With Immune Checkpoint Inhibitor: Case Report and Literature Review 47
Prognostic factors in metastatic castration resistant prostate cancer patients treated with Radium-223: a retrospective study 46
Role of radium-223 discontinuation due to adverse events in castration-resistant prostate cancer patients. A retrospective monocentric analysis 43
Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with Abiraterone or Enzalutamide 42
Are tyrosine kinase inhibitors an effective treatment in testicular metastases from kidney cancer? Case report 42
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine? 39
New emerging targets in advanced urothelial carcinoma: Is it the primetime for personalized medicine? 36
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation-based therapy 35
Prognostic role of early PSa drop in castration resistant prostate cancer patients treated with abiraterone acetate or enzalutamide 33
Therapeutic sequencing in advanced renal cell carcinoma: how to choose considering clinical and biological factors 31
Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications 31
New Perspectives in the Medical Treatment of Non-Muscle-Invasive Bladder Cancer: Immune Checkpoint Inhibitors and Beyond 26
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy? 23
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma 16
Synthetic Lethality by Co-Inhibition of Androgen Receptor and Polyadenosine Diphosphate-Ribose in Metastatic Prostate Cancer 12
Impact of Neuroendocrine Differentiation (NED) on Enzalutamide and Abiraterone Efficacy in Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Retrospective Analysis 4
Hormonal Agents in Localized and Advanced Prostate Cancer: Current Use and Future Perspectives 3
Totale 2.686
Categoria #
all - tutte 9.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.588


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020150 0 0 0 16 9 21 15 19 19 20 13 18
2020/2021335 12 17 33 33 39 25 26 33 30 27 17 43
2021/2022411 40 18 20 9 15 6 22 25 19 57 128 52
2022/2023852 52 90 33 59 84 152 57 63 99 51 65 47
2023/2024580 52 71 41 58 32 83 62 40 9 42 35 55
2024/2025211 47 84 62 18 0 0 0 0 0 0 0 0
Totale 2.686